10 years of data collected in the Berlin Myocardial Infarction Registry (BMIR) – Changes in treatment and outcome for patients with acute myocardial infarction

Background: Over a decade of years, from 1999–2008, guidelines for treatment of patients with myocardial infarction (MI) have been regularly updated and new definitions for acute MI have been established. Aim of the present study was to investigate the changes in treatment and hospital mortality over this 10-year period in acute MI-patients under the influence of the implementation of guideline-based therapy and the redefinition of acute myocardial infarction in Berlin, Germany. Methods: In the BMIR, data of patients with acute myocardial infarction (AMI) have been collected prospectively since 1999. We analyzed data from 1.1.1999–1.4.2008 of 11 hospitals continuously participating in the BMIR. We consecutively included 9830 MI patients. Demographic data, data on reperfusion therapy and discharge medication, and on hospital mortality were analyzed. Results: *p Chi Square Trend Test 1999/2000 N=1645 2001/2002 n=1719 2003/2004 n=2250 2005/2006 N=2327 2007/1.4.2008 n=1889 p* female gender 33.9% 33.2% 36.0% 35.4% 32.3% 0.633 Age >75 years 30.6% 27.2% 30.4% 34.5% 27.9% 0.413 Time from symptom onset to hospital arrival ≤2h 48.7% 47.8% 42.6% 41.7% 42.2% <0.001 STEMI (vs. NSTEMI) 76.4% 76.1% 62.6% 54.4% 49.5% <0.001 Physician escorted rescue system 44.1% 42.0% 44.3% 50.1% 49.6% <0.001 Primary PCI 18.4% 40.4% 62.3% 76.8% 79.9% <0.001 Thrombolysis 40.6% 29.8% 9.8% 3.4% 1.1% <0.001 ASA and/or clopidogrel on discharge 91.1% 94.5% 97.1% 96.7% 97.7% <0.001 Beta-blockers on discharge 70.3% 76.8% 76.8% 84.5% 87.8% <0.001 ACE-inhibitors and/or ARBs on discharge 76.5% 83.9% 89.5% 89.3% 92.4% <0.001 CSE-inhibitors on discharge 39.8% 57.5% 69.1% 76.8% 85.3% <0.001 hospital-mortality 12.2% 11.8% 8.5% 7.8% 6.2% <0.001 Conclusions: Over the 10 year period the total number and the percentage of NSTEMI-patients increased probably due to redefinition of acute myocardial infarction. Adherence to guidelines increased and hospital mortality was lowered, but time between symptom onset and hospital arrival increased.